SGLT2 Inhibition Reduces Insulin Use in CKD and Type 2 Diabetes
The following is a summary of “Effects of SGLT2 inhibition on insulin use in CKD and type 2 diabetes: Insights from the CREDENCE trial,” published in the February 2025 issue of Nephrology Dialysis Transplantation by ...
